Showing the value of regulatory intelligence in pharma

Update: 2021-10-11

Description

In this episode of Conversations in Healthcare, Mike Ward speaks with Carolyn Hynes, Director of Regulatory Intelligence at AstraZeneca, and Céline Rodier, Senior Health Policy Manager at Clarivate, about strategies and tools to gather and assess regulatory intelligence, as well as KPIs and approaches to demonstrating ROI within your organization. Get actionable takeaways in the full episode.

Hosted on Acast. See acast.com/privacy for more information.

Comments

In Channel

Lighting the touch paper for next generation nucleic acid therapies

2023-05-0332:06

Realizing the patient-friendly future of clinical trials

2022-07-0523:02

How Patient Connect addresses unmet needs at the point of care

2022-04-1822:32

Social determinants: barriers to healthcare impacting racial and ethnic minorities

2022-02-1045:59

How Novo Ventures prioritized their investment strategy during the pandemic

2021-12-1325:50

How Healx uses AI to transform rare disease drug discovery

2021-12-0127:52

How the pandemic shifted Roche’s priorities and R&D investments

2021-11-1531:20

Optimizing patient-first clinical trials with advanced site intelligence

2021-11-0240:56

Showing the value of regulatory intelligence in pharma

2021-10-1131:32

Overcoming health inequity in the U.S. and the role of telehealth: Ideas and best practices from Cigna, Henry Ford Health System and the eHealth Initiative

2021-09-2136:46

Best practices for university - healthcare partnerships: Learnings from the Institute of Cancer Research

2021-08-1927:59

Best practices for university – healthcare partnerships: Learnings from Oxford

2021-07-3135:15